Every SEC Form 3/4/5 on record for this filer (CIK 1539215) — 1 issuer, 114 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Sr. VP of IP, CSO | 2015-11-06 → 2026-03-18 | 63 | −$20M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| SUPN | 2026-03-18 | Sell | 6,838 | $49.55 | $338,823 | 17,456 |
| SUPN | 2026-03-18 | Sell | 412 | $50.48 | $20,798 | 17,044 |
| SUPN | 2026-03-17 | Sell | 22,290 | $50.73 | $1M | 17,044 |
| SUPN | 2026-03-17 | Sell | 27,710 | $49.95 | $1M | 39,334 |
| SUPN | 2026-03-16 | Sell | 15,886 | $50.49 | $802,084 | 17,044 |
| SUPN | 2026-03-16 | Sell | 34,114 | $50.18 | $2M | 32,930 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.